Steven E. Ducommun
- Chicago
- Madison
Steve represents clients in connection with mergers and acquisitions, strategic alliances, commercial contracting, and financings.
Steve Ducommun provides guidance on formation issues, research and development arrangements (biotech, life sciences, and ag), and commercial matters, including technology commercialization, licensing, manufacturing, and distribution. Steve works with companies in a range of industries, including healthcare, biotechnology, food and procurement (rep cooperatives), cleantech, pharmaceutical, medical devices, agtech and agribusiness, and tech.
Steve represents companies in acquisitions and sales, serving as primary outside counsel to mature companies, as well as to early-and growth-stage companies in the healthcare, life sciences, and cleantech industries.
Areas of focus
Industries
Services
Education & Credentials
Education
- Cornell Law School, J.D., cum laude, Board of Editors, Cornell Law Review, 1986
- The University of Chicago Law School, Visiting Student, 1986
- Drake University, B.S., summa cum laude, Beta Gamma Sigma, 1979
Bar and Court Admissions
-
Illinois
-
Wisconsin
- U.S. District Court for the Northern District of Illinois
Related Employment
- K&L Gates LLP (formerly Bell, Boyd and Lloyd), Chicago, IL, Attorney
Impact
Professional Leadership
- American Bar Association
- French American Chamber of Commerce
- Illinois Biotechnology Innovation Organization (iBIO)
PROPEL
Executive Committee, Secretary, 2017 - present
Board of Directors, 2005 - present
- Polsky Center for Entrepreneurship and Innovation - The University of Chicago, workshop presenter, 2015 - present
- 1871 - Chicago's Technology & Entrepreneurship Center, workshop presenter, 2015 - present
- Chicago Innovation Mentors, mentor, 2014 - present
News
Professional Experience
Business
National Ambulatory Surgery Management Company*
Representation of national ambulatory surgery management company in its private equity backed financings, numerous acquisitions and joint ventures, public offerings and sale for $600 million.
Provider of Rehabilitation Health Care*
Representation of the largest provider of rehabilitation health care in numerous private security syndications.
Pharmaceutical Company*
Representation of a pharmaceutical company in numerous commercial transactions, including negotiation of development, manufacturing and distribution agreements.
Medical Device Corporation*
Representation of a major multi-national medical device corporation in the negotiation of a new product development arrangement for its next generation device with an independent research and development company.
Genetic Engineering Firm*
Representation of a genetic engineering firm in its formation, venture-backed equity financings, and major research alliances with multi-national leaders in agricultural biotechnology.
Major Procurement Cooperative*
Representation of a major procurement cooperative in its transactional, commercial, regulatory and corporate governance matters, including acquisitions, strategic alliances and investments.
Major Hedge Fund*
Representation of a major hedge fund in connection with its investment in a novel cleantech venture.
Private Equity And Venture Capital Funds*
Representation of a number of private equity and venture capital funds in connection with equity and debt financings, merger and acquisition transactions, and research alliances with respect to their portfolio companies.
Research Consortium*
Representation of research consortium in numerous research and development agreements in the biotechnology field.
* Prior Experience